Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.

Functional Genomic Screening October 30, 2025 - 3 min read
Read
Small Molecule Drug Discovery

Improving drug safety through cardiotoxicity assessment.

April 29, 2024 - 2 min read
Read
Small Molecule Drug Discovery

Cancer-killing seaweed.

April 29, 2024 - 3 min read
Read
NGS

Existing depletion technologies for Next-Generation Sequencing (NGS).

April 26, 2024 - 2 min read
Read
Cancer

Fluorescence imaging is comparable to PET in early detection of tumor metabolism.

April 25, 2024 - 4 min read
Read
Cancer

The top 7 attributes of cell line-derived reference standards for oncology assays.

April 25, 2024 - 2 min read
Read
Cell and Gene Therapy

The future of cell and gene therapy: Revvity at ASGCT.

April 23, 2024 - 2 min read
Read
NGS

Limitations associated with the lack of data analysis tools in metagenomics.

April 16, 2024 - 2 min read
Read
Cancer, Drug Development, Disease Research

Why use fluorescent probes in your in vivo imaging studies?

April 9, 2024 - 3 min read
Read
Physiological Model Solutions, Cancer

Overcoming the challenges of 3D immune cell-killing assays.

April 5, 2024 - 2 min read
Read
Physiological Model Solutions, Automation

Making organoids ready for screening.

April 5, 2024 - 3 min read
Read
Pagination
  • First page « 最初
  • Previous page Previous
  • …
  • ページ 23
  • ページ 24
  • ページ 25
  • ページ 26
  • Current page 27
  • ページ 28
  • ページ 29
  • ページ 30
  • ページ 31
  • …
  • Next page Next
  • Last page 最後 »
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.